Bicocca Open Archive

Logo unimib boa
CROTTI, LIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.408
AS - Asia 13.679
EU - Europa 8.292
SA - Sud America 1.980
AF - Africa 325
OC - Oceania 68
Continente sconosciuto - Info sul continente non disponibili 8
Totale 41.760
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.012
SG - Singapore 4.921
CN - Cina 2.651
HK - Hong Kong 2.077
VN - Vietnam 2.005
IT - Italia 1.863
RU - Federazione Russa 1.666
BR - Brasile 1.452
IE - Irlanda 877
DE - Germania 818
SE - Svezia 740
GB - Regno Unito 534
FR - Francia 433
IN - India 350
ID - Indonesia 295
UA - Ucraina 242
AR - Argentina 217
CA - Canada 207
KR - Corea 204
BD - Bangladesh 202
ES - Italia 169
JP - Giappone 169
FI - Finlandia 163
NL - Olanda 162
TR - Turchia 143
IQ - Iraq 136
AT - Austria 132
MX - Messico 116
ZA - Sudafrica 102
PL - Polonia 90
CO - Colombia 74
DK - Danimarca 72
PK - Pakistan 70
EC - Ecuador 68
SA - Arabia Saudita 64
CH - Svizzera 61
PH - Filippine 61
AU - Australia 54
CL - Cile 48
VE - Venezuela 47
BE - Belgio 45
MA - Marocco 44
UZ - Uzbekistan 40
GR - Grecia 36
KE - Kenya 32
MY - Malesia 31
PT - Portogallo 31
ET - Etiopia 29
LT - Lituania 27
PY - Paraguay 27
AE - Emirati Arabi Uniti 26
TH - Thailandia 23
JO - Giordania 22
RO - Romania 22
TN - Tunisia 22
DZ - Algeria 20
AZ - Azerbaigian 19
JM - Giamaica 19
UY - Uruguay 19
IL - Israele 18
PE - Perù 18
TW - Taiwan 18
CZ - Repubblica Ceca 17
EG - Egitto 17
KZ - Kazakistan 16
NP - Nepal 16
RS - Serbia 16
NZ - Nuova Zelanda 14
OM - Oman 13
SN - Senegal 13
IR - Iran 12
KW - Kuwait 12
AL - Albania 11
BY - Bielorussia 11
DO - Repubblica Dominicana 10
HR - Croazia 9
NG - Nigeria 9
CR - Costa Rica 8
HU - Ungheria 8
KG - Kirghizistan 8
SC - Seychelles 8
BG - Bulgaria 7
HN - Honduras 7
LB - Libano 7
NO - Norvegia 7
PS - Palestinian Territory 7
BA - Bosnia-Erzegovina 6
BH - Bahrain 6
BO - Bolivia 6
GE - Georgia 6
GT - Guatemala 6
PA - Panama 6
AM - Armenia 5
LK - Sri Lanka 5
SI - Slovenia 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CY - Cipro 4
MN - Mongolia 4
Totale 41.691
Salva come PNG Salva come JPEG
Città #
Singapore 2.811
Hong Kong 2.032
Fairfield 1.558
Ashburn 1.487
Ann Arbor 1.273
San Jose 925
Dublin 825
Chandler 741
Woodbridge 698
Wilmington 680
Houston 620
Ho Chi Minh City 618
Seattle 594
Santa Clara 553
New York 528
Dearborn 501
Hanoi 499
Cambridge 495
Milan 478
Frankfurt am Main 474
Chicago 436
Princeton 363
Council Bluffs 339
Dallas 331
The Dalles 321
Hefei 293
Los Angeles 290
Beijing 277
Jakarta 239
Lauterbourg 217
Seoul 179
Nanjing 174
Lawrence 161
Moscow 157
Jacksonville 155
Altamura 152
São Paulo 139
Buffalo 128
Rome 114
San Diego 107
Helsinki 105
Tokyo 98
London 96
Guangzhou 94
Nuremberg 93
Vienna 92
Da Nang 88
Shanghai 84
Haiphong 71
Toronto 70
Shenyang 63
Warsaw 62
Hebei 60
Jinan 59
Andover 58
Phoenix 58
Salt Lake City 58
Orem 57
Munich 56
Nanchang 56
Atlanta 53
Baghdad 51
Hangzhou 50
Chennai 49
Changsha 48
Amsterdam 47
Rio de Janeiro 46
Belo Horizonte 44
Zhengzhou 43
Denver 42
Montreal 42
Johannesburg 41
Madrid 41
Dhaka 39
Boardman 38
Tianjin 38
Istanbul 36
Biên Hòa 35
Dong Ket 35
Lappeenranta 35
San Francisco 34
Tashkent 34
Buenos Aires 33
Columbus 33
Jiaxing 33
Stockholm 32
Elk Grove Village 31
Sesto San Giovanni 31
New Delhi 30
Quận Bình Thạnh 30
Boston 29
Brooklyn 29
Norwalk 28
Hải Dương 27
Tampa 27
Washington 27
Addis Ababa 26
Nairobi 26
Ottawa 26
Lahore 25
Totale 25.884
Salva come PNG Salva come JPEG
Nome #
Indications and utility of cardiac genetic testing in athletes 596
Genetic mechanisms of critical illness in COVID-19 511
International Triadin Knockout Syndrome Registry: The Clinical Phenotype and Treatment Outcomes of Patients with Triadin Knockout Syndrome 499
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 483
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 472
Continuous Rhythm Monitoring With Implanted Loop Recorders in Children and Adolescents With Brugada Syndrome 467
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 444
Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients 420
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis 409
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes 345
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 343
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 343
Mapping the human genetic architecture of COVID-19 333
Investigation on Sudden Unexpected Death in the Young (SUDY) in Europe: results of the European Heart Rhythm Association Survey 330
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 316
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 309
Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome. 305
Long QT Syndrome and Brugada Syndrome : 2 aspects of the same disease? 294
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications] 282
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 265
Partial Pericardial Agenesis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy 260
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 255
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome 253
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 249
Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome 244
Biventricular arrhythmogenic cardiomyopathy: a paradigmatic case. 241
Infanticide vs. inherited cardiac arrhythmias. 227
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 216
An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition 215
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 215
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 212
Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy 211
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 209
Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry 206
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5 205
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 205
The ICD for the long QT syndrome: which indications, complications, and results? 201
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 200
An explainable model of host genetic interactions linked to COVID-19 severity 199
Clinical Implications for Patients With Long QT Syndrome Who Experience a Cardiac Event During Infancy 199
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification 199
A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK) 198
AKAP9 is a genetic modifier of congenital long-QT syndrome type 1 196
To be, or not to be engaged in sport activities, that is the amletic question for patients with coronary artery disease 195
Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca [Rationale and significance of the Italian Network for Cardiac Amyloidosis] 194
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 194
Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations 193
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Nav1.5 and Kv4.3 channel currents 193
Calmodulin mutations and life-threatening cardiac arrhythmias: Insights from the International Calmodulinopathy Registry 193
Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families 192
Prevalence of the congenital long-qt syndrome 192
Response by Crotti et al to Letter Regarding Article, "genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1?" 191
Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies 191
Whole-genome sequencing reveals host factors underlying critical COVID-19 190
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge 189
The Long QT Syndrome 189
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms 187
The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome 187
Response to Letters Regarding Article, "clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 186
Neuroimmune crosstalk in the pathophysiology of hypertension. 185
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome 185
Metabolic adaptations to cardiac rehabilitation through physical exercise: Insights from untargeted metabolomics using dried blood spots in post-myocardial infarction patients 184
The genetics underlying acquired long QT syndrome: Impact for genetic screening 184
The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia? 184
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroups. 184
Long and Short QT syndromes. 184
aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study 183
Corrigendum to “Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis” [International Journal of Cardiology Volume 357, 15 June 2022, Pages 88–94]. (International Journal of Cardiology (2022) 357 (88–94), (S0167527322003850), (10.1016/j.ijcard.2022.03.028)) 182
Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes 182
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1 182
Inherited Cardiac Arrhythmia Syndrome: Role of Potassium Channels 182
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 182
Cardiac potassium channel dysfunction in sudden infant death syndrome 181
Low-pass filtering approach via empirical mode decomposition improves short scale entropy-based complexity estimation of QT interval variability in Long QT Syndrome Type 1 patients 180
Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations 180
Brugada and Long QT Syndrome are two different diseases: True or False? 180
Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation? 179
Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors 179
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome 178
Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome 175
Multiplexed Assays of Variant Effect and Automated Patch Clamping Improve KCNH2-LQTS Variant Classification and Cardiac Event Risk Stratification 174
Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19 174
Mutation-Specific Risk in Two Genetic Forms of Type 3 Long QT Syndrome 174
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome 174
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 173
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome 173
Cardiac sodium channel dysfunction in sudden infant death syndrome 173
Gain of function mutation, S422L, in the KCNJ8-encoded cardiac K ATP channel Kir6.1 as a pathogenic substrate for J wave syndromes 173
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation 172
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population 171
QTc behavior during exercise and genetic testing for the long-QT syndrome 171
Clinical Features, Long-Term Prognosis, and Clinical Management of Genotype-Negative Long QT Syndrome Patients 170
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 170
Frequency of and outcomes associated with nonadherence to guideline-based recommendations for an implantable cardioverter-defibrillator in patients with congenital long QT syndrome 169
Efficacy and safety of cardiac rehabilitation in patients with left ventricular thrombosis after acute myocardial infarction 169
Genetic of adult and fetal forms of Long QT Syndrome. 168
A refined multiscale self-entropy approach for the assessment of cardiac control complexity: Application to long QT syndrome type 1 patients 167
Ion channel diseases in children: Manifestations and management 167
The role of genetics in primary ventricular fibrillation, inherited channelopathies and cardiomyopathies 166
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome 166
Totale 23.066
Salva come PNG Salva come JPEG
Categoria #
all - tutte 147.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.930
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021599 0 0 0 0 0 0 0 0 0 231 181 187
2021/20221.909 153 163 235 85 61 117 117 152 95 208 221 302
2022/20233.996 425 913 301 350 274 652 92 261 354 65 169 140
2023/20243.086 124 162 157 89 420 709 509 107 300 92 79 338
2024/20258.756 466 1.208 617 332 622 347 456 358 1.061 1.102 673 1.514
2025/202616.356 1.772 1.303 1.285 1.696 2.059 1.051 2.567 964 2.084 1.575 0 0
Totale 43.082